搜索筛选:
搜索耗时4.1409秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
[期刊论文] 作者：Wenxin Li,Jinxiang Fu,Fengming,
来源：中国免疫学杂志（英文版） 年份：2004
...
Carfilzomib promoted osteogenic differentiation potential of mesenchymal stem cells from myeloma pat
[会议论文] 作者：Xueping Ge,Jun Li,Qian Wang,Yali Li,Xiaohui Zhang,Ping Chen,Jinxiang Fu,Bingzong Li,Wenzhuo Zhuang,
来源：The 35th World Congress of the International Society of Hema 年份：2014
...
Carfilzomib promoted osteogenic differentiation potential of mesenchymal stem cells from myeloma pat
[会议论文] 作者：Xueping Ge,Jun Li,Wenzhuo Zhuang,Qian Wang,Yali Li,Xiaohui Zhang,Ping Chen,Jinxiang Fu,Bingzong Li,
来源：The 35th World Congress of the International Society of Hema 年份：2014
Aim Notch1 signaling plays a key role in the differentiation of mesenchymal stem cells (MSCs).Carfilzomib (CFZ),a second-generation proteasome inhibitor,has poten tcytotoxicity against myeloma cells.I...
Local low-dose X-ray radiation promotes homing of mesenchymal stem cells to the injured mouse spinal
[期刊论文] 作者：,Xiaohui Zhang,Leixi Xue,Yu Sun,Songguang Ju,Liesong Chen,Jiasheng Hu,Hong Zhang,Xueguang Zhang,Jinxiang Fu,
来源：中国神经再生研究（英文版） 年份：2010
BACKGROUND: Bone marrow-derived mesenchymal stem cells (BMSCs) are a potentially useful source for cell replacement therapy following spinal cord injury. Howeve...
Phase 1 studies comparing safety, tolerability, pharmacokinetics and pharmacodynamics of HLX01(a rit
[期刊论文] 作者：Yuankai Shi,Qingyuan Zhang,Xiaohong Han,Yan Qin,Xiaoyan Ke,Hang Su,Li Liu,Jinxiang Fu,Jie Jin,Jifeng,
来源：中国癌症研究:英文版 年份：2021
Objective: This study aimed to compare the pharmacokinetic, pharmacodynamic and safety profiles of HLX01(a rituximab biosimilar) and reference rituximab sourced from China(Mab Thera?;rituximab-CN).Methods: Here we report the results of two ......
[会议论文] 作者：Yingyun Gong,Zhenzhen Fu,Ying Zhou,Aijie Huang,Panpan Yang,Wen Guo,Jinxiang Fu,Xiaohui Zhu,Beibei Gao,
来源：The 2016 International Conference on Lipid Metabolism and Bi 年份：2016
...
Phase 1 studies comparing safety,tolerability,pharmacokinetics and pharmacodynamics of HLX01(a ritux
[期刊论文] 作者：Yuankai Shi,Qingyuan Zhang,Xiaohong Han,Yan Qin,Xiaoyan Ke,Hang Su,Li Liu,Jinxiang Fu,Jie Jin,Jifeng,
来源：中国癌症研究（英文版） 年份：2004
Objective:This study aimed to compare the pharmacokinetic,pharmacodynamic and safety profiles of HLX01(a rituximab biosimilar)and reference rituximab sourced fr...
相关搜索：
